TY  - GEN
AU  - Papayannidis,C
AU  - DeAngelo,D J
AU  - Stock,W
AU  - Huang,B
AU  - Shaik,M N
AU  - Cesari,R
AU  - Zheng,X
AU  - Reynolds,J M
AU  - English,P A
AU  - Ozeck,M
AU  - Aster,J C
AU  - Kuo,F
AU  - Huang,D
AU  - Lira,P D
AU  - McLachlan,K R
AU  - Kern,K A
AU  - Garcia-Manero,G
AU  - Martinelli,G
TI  - A Phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma
SN  - 2044-5385
PY  - 2016///0125
KW  - Adolescent
KW  - Adult
KW  - Antineoplastic Agents
KW  - pharmacokinetics
KW  - Female
KW  - High-Throughput Nucleotide Sequencing
KW  - Humans
KW  - Male
KW  - Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
KW  - drug therapy
KW  - Receptor, Notch1
KW  - genetics
KW  - Tetrahydronaphthalenes
KW  - therapeutic use
KW  - Valine
KW  - analogs & derivatives
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase I; Letter; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/bcj.2015.80
ER  -